Language And Country


14 Boulevard Royal L-2449 Luxembourg
Monday to Friday
8.30 am to 5 pm
Chaussée de La Hulpe, 120 – 1000 Brussels
Kortrijksesteenweg 218 – 9830 Sint-Martens-Latem
Monday to Friday
8.30 am to 4.30 pm

MENU - Mon Compte

Détail d'un fonds

Funds Detail

BL European Family Businesses

Equity funds

Data as of 10/06/2021

Risk level

Recommended investment horizon : > 10 years


Average annual performance since launch 9,32 %

Performance as at 10/06/2021

2018-17,43 %
201921,20 %
20204,51 %
Since 01/01/202112,53 %
Over the last 12 months30,16 %
Over 3 years17,93 %
Since launch49,49 %
Asset breakdown
Equities94,39 %
Cash5,61 %
Breakdown by currency
EUR78,87 %
CHF14,01 %
SEK2,51 %
GBP2,37 %
DKK1,93 %
Others0,30 %
Main positions
Grifols SA A3,93 %
Bossard Holding AG3,76 %
Stroeer SE + Co KGaA3,65 %
Datalogic SPA Post Frazionamento3,51 %
Societe Virbac SA3,44 %


Investment objective and policy

The BL-European Family Businesses fund invests in european equities regardless of market capitalisation. Companies are defined as family businesses if the person or family that founded the company or acquired the company's capital owns at least 25% of its shares, or if the family in question controls the business's strategy and operations. The portfolio structure is the outcome of the addition of individual investment opportunities rather than a replication of a market benchmark. The sub-fund's objective is long-term capital growth.

Management report - 1st Quarter 2021

During the first quarter of 2021, the MSCI Europe Smid Net Return, the fund's benchmark, gained 8.24%. January was marked by a return to investor caution in the face of uncertainty about the timing of the economic recovery given the spread of Covid variants. In February, the epidemic receded, leading to a renewed appetite for risk and a sharp increase in 'value' and cyclical stocks at the expense of long duration and defensive stocks. Renewed support from governments and central banks sustained this fresh bout of optimism in March and contributed to an acceleration in the market's rise and continuation of the sector rotation. This market context was not very favourable for BL European Family Businesses, and the fund (B share, accumulation) generated performance of +3.76%. The portfolio's performance was boosted by Datalogic, Basler, Eurofins Scientific, Dormakaba and Bossard. Datalogic benefited from the recovery in industrial automation sales and continued growth in China, both of which are medium-term growth drivers. Basler advanced thanks to increased revenues from semiconductor customers in Asia as well as strong demand from the logistics end market. Eurofins saw its revenues increase from its Covid-19 testing activities - PCR, serology, surface and home kits - and the spread of different variants increased the need for high-sensitivity identification of Covid-19 mutations. Dormakaba has successfully implemented a cost savings and restructuring programme and the gradual improvement in the business is helping to boost its share price. Bossard is benefiting from the general recovery in its end markets. Its customers appreciate the company's consistent ability to deliver, and its focus on the industries of the future is also paying off. The main detractors from performance during the quarter were Stroeer, Virbac, Rational, Systemair and SoftwareOne. During the quarter, we sold Barry Callebaut, Roche and Stef and opened a new position in SoftwareOne.

General information

Net Asset Value 
Calculated Every business day
NAV class B capitalisation shares (10/06/2021)149,49 EUR
CODESISIN capitalisation code : LU1305479153
WKN capitalisation code : A1421F
Net assets (million)131,60 EUR
Launch date06/12/2016

Détail fonds - disclaimer

Before making any decision to subscribe, customers must ensure they have understood the product, having measured the risks associated with it and consulted their own advisers on the appropriateness of the product for their particular financial situation, taking into account legal, tax and accounting aspects. This fact sheet has been drawn up for information purposes and shall in no event be considered a solicitation to buy or an offer to sell securities or other financial instruments. Information provided to the interested party does not constitute legal or fiscal advice and the Bank shall not be held liable for such information. The securities referred to in this document may cause the investor to incur significant risk and may not be appropriate for all investors. Such risks include market risks, high volatility, credit risk, liquidity risk and interest-rate risk. There is no guarantee that the securities described in this document will achieve their investment objectives. Past performance is no indication of future returns. The Bank shall not be held liable for the future performance of these securities. Potential investors must ensure that they understand the risks of investing in such products and should only take an investment decision after giving careful consideration, together with their professional advisers, to the appropriateness of this investment to their specific financial situation, particularly with regard to legal, tax and accounting aspects. We have made every effort to verify that the information presented in this document is correct, in particular the estimated values, opinions and other estimates. Nevertheless, no guarantee can be given as to the validity, timeliness, completeness, correctness or accuracy of the information, which is provided for guidance only. Information may be subject to change without prior notice.

Page détail fonds - Retour au tableau